FLUDEOXYGLUCOSE [F-18] FDG INJECTION
Google image searchProduct monograph
Active ingredient
fludeoxyglucose 18f, 0.5 GBQ/VIAL
DIN: 02467151
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: MULTIDOSE VIALS
Schedule: Schedule C
Company: THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE
Date: 20-OCT-2021
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09I — TUMOUR DETECTION (ATC, ATC/DDD)
- V09IX — Other diagnostic radiopharmaceuticals for tumour detection (ATC, ATC/DDD)
- V09IX04 — FLUDEOXYGLUCOSE (18F) (ATC/DDD)
Pharmaceutical standard: USP
